BioCentury
ARTICLE | Clinical News

PEG-hemoglobin oxygen carrier: ENZN began a safety trial of PEG-hemoglobin, followed by radiation therapy.

July 1, 1996 7:00 AM UTC

Enzon Inc. (ENZN), Piscataway, N.J. Product: PEG-hemoglobin oxygen carrier Use: Increase tumor oxygenation in cancer radiation therapy Status: ENZN began a safety trial of once-weekly infusions of PEG...